ZA200907052B - Aliphatic acid-containing n-halogenated amino acid formulations - Google Patents

Aliphatic acid-containing n-halogenated amino acid formulations

Info

Publication number
ZA200907052B
ZA200907052B ZA2009/07052A ZA200907052A ZA200907052B ZA 200907052 B ZA200907052 B ZA 200907052B ZA 2009/07052 A ZA2009/07052 A ZA 2009/07052A ZA 200907052 A ZA200907052 A ZA 200907052A ZA 200907052 B ZA200907052 B ZA 200907052B
Authority
ZA
South Africa
Prior art keywords
amino acid
formulations
halogenated amino
acid
aliphatic
Prior art date
Application number
ZA2009/07052A
Other languages
English (en)
Inventor
Masood A Chowhan
Wesley Wehsin Han
L Wayne Schneider
David W Stroman
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of ZA200907052B publication Critical patent/ZA200907052B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Eyeglasses (AREA)
ZA2009/07052A 2007-05-01 2009-10-09 Aliphatic acid-containing n-halogenated amino acid formulations ZA200907052B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91527107P 2007-05-01 2007-05-01
PCT/US2008/061950 WO2008134692A1 (en) 2007-05-01 2008-04-30 Aliphatic acid-containing n-halogenated amino acid formulations

Publications (1)

Publication Number Publication Date
ZA200907052B true ZA200907052B (en) 2010-12-29

Family

ID=39616420

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2009/07052A ZA200907052B (en) 2007-05-01 2009-10-09 Aliphatic acid-containing n-halogenated amino acid formulations

Country Status (17)

Country Link
US (2) US20080275126A1 (enExample)
EP (1) EP2139520B1 (enExample)
JP (2) JP2010526084A (enExample)
KR (1) KR20100017156A (enExample)
CN (1) CN101678105A (enExample)
AR (1) AR066371A1 (enExample)
AU (1) AU2008245460B2 (enExample)
BR (1) BRPI0811073A2 (enExample)
CA (1) CA2684101A1 (enExample)
CL (1) CL2008001283A1 (enExample)
ES (1) ES2432408T3 (enExample)
MX (1) MX2009011817A (enExample)
RU (1) RU2009144291A (enExample)
TW (1) TW200902092A (enExample)
UY (1) UY31057A1 (enExample)
WO (1) WO2008134692A1 (enExample)
ZA (1) ZA200907052B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2265267B1 (en) * 2008-04-10 2016-09-21 Waldemar Gottardi Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections
WO2009127924A1 (en) * 2008-04-15 2009-10-22 Waldemar Gottardi Compositions and devices for antisepsis and anticoagulation
CN113729039A (zh) * 2021-08-27 2021-12-03 上海罗克环控节能科技股份有限公司 一种绿色环保消毒液及其制造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6027965B2 (ja) * 1980-02-23 1985-07-02 東洋コンタクトレンズ株式会社 コンタクトレンズに付着した汚れの除去方法
US5421818A (en) * 1993-10-18 1995-06-06 Inner Ear Medical Delivery Systems, Inc. Multi-functional inner ear treatment and diagnostic system
AU3070395A (en) * 1994-07-22 1996-02-22 Alcon Laboratories, Inc. Use of low molecular weight amino acids in ophthalmic compositions
US6156728A (en) * 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
US6387427B1 (en) * 2000-09-28 2002-05-14 Nestec S.A. Method of preservation of a food product
WO2003061566A2 (en) * 2002-01-24 2003-07-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Anti-cancer combination and use thereof
PL1656095T3 (pl) * 2003-08-18 2014-04-30 Novabay Pharmaceuticals Inc N,n-dwuchlorowcowane kwasy aminowe i pochodne
TWI386201B (zh) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc N-鹵化胺基酸、n,n-二鹵化胺基酸與其衍生物;以及使用其之組合物與方法
TWI432231B (zh) * 2005-10-06 2014-04-01 Novabay Pharmaceuticals Inc 使用n-鹵化胺基酸於預防包括泌尿道感染(uti)之細菌性與真菌性感染的系統與方法

Also Published As

Publication number Publication date
CA2684101A1 (en) 2008-11-06
BRPI0811073A2 (pt) 2014-12-09
UY31057A1 (es) 2008-10-31
KR20100017156A (ko) 2010-02-16
MX2009011817A (es) 2009-11-13
TW200902092A (en) 2009-01-16
CN101678105A (zh) 2010-03-24
RU2009144291A (ru) 2011-06-10
JP2010526084A (ja) 2010-07-29
WO2008134692A1 (en) 2008-11-06
ES2432408T3 (es) 2013-12-03
EP2139520B1 (en) 2013-08-21
EP2139520A1 (en) 2010-01-06
AR066371A1 (es) 2009-08-12
JP2014098037A (ja) 2014-05-29
US20080275126A1 (en) 2008-11-06
AU2008245460B2 (en) 2013-08-22
CL2008001283A1 (es) 2009-01-16
US20110060044A1 (en) 2011-03-10
AU2008245460A1 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
HRP20170206T1 (hr) Alkilamino-supstituirani dicijanopiridini i njihovi predlijekovi estera amino kiseline
EP2116238A4 (en) Amino acid composition
SI2194969T1 (sl) Lipidne formulacije, ki vsebujejo kislino
LT2494993T (lt) Aminorūgščių lipidai ir jų panaudojimas
PL2462223T3 (pl) Oksydaza fruktozyloaminokwasowa
PL2407475T3 (pl) Przygotowywanie syntetycznych kwasów żółciowych
ZA201108850B (en) Solid compositions comprising 5-aminolevulinic acid
IL218231A0 (en) Vesicular formulations
PL2358662T3 (pl) Sposób amonolizy kwasu 11-bromoundekanowego
ZA200907050B (en) N-halogenated amino acid formulations
EG25838A (en) Process for the preparation of amino acid methyl esters
AP2495A (en) Use of gamma-aminobutyric acid as a depigmentationagent
GB0713189D0 (en) Amino acid derivatives
BRPI0810962A2 (pt) Formulações de aminoácidos n-halogenados com compostos anti-inflamatórios
ZA201102450B (en) Amino acid derivative
ZA200907052B (en) Aliphatic acid-containing n-halogenated amino acid formulations
GB0715712D0 (en) Amino acid derivatives
GB0624084D0 (en) Ramipril amino acid salts
ZA201004864B (en) Amino acid derivatives used as pharmaceutical substances
GB0602780D0 (en) Amino Acid Derivatives
HK1133587A (en) Aliphatic acid-containing n-halogenated amino acid formulations
HK1133836A (en) N-halogenated amino acid formulations
HK1133835A (en) N-halogenated amino acid formulations with anti-inflammatory compounds
HK1133589A (en) N-halogenated amino acid formulations and methods for cleaning and disinfection
GB0906872D0 (en) Amino acid derivatives